期刊文献+
任意字段
题名或关键词
题名
关键词
摘要
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息
共找到1篇文章
< 1 >
每页显示 20 50 100
已选0条
引用分析
参考文献
引证文献
 统计分析
检索结果
已选文献
显示方式：
Cardiomyopathies of endocrine origin: A state-of-the-art review 认领 引用
1
作者 Jenyfer M Fuentes-Mendoza Marcio J Concepción-Zavaleta +7 位作者 Juan C Morón-Siguas Juan M Muñoz-Moreno Aranza I Pérez-Reyes Rodrigo Martinez-Galaviz Raúl D Aguilar-Castañeda Oziel González-Godoy Luis A Concepción-Urteaga José Paz-Ibarra 《World Journal of Cardiology》 2025年第10期20-41,共22页
Endocrine disorders are increasingly recognized as potentially reversible causes of secondary cardiomyopathies,yet they often remain underdiagnosed in clinical practice.These conditions-including thyroid dysfunction,a... Endocrine disorders are increasingly recognized as potentially reversible causes of secondary cardiomyopathies,yet they often remain underdiagnosed in clinical practice.These conditions-including thyroid dysfunction,acromegaly,pheochromocytoma,diabetes mellitus,adrenal disorders,among others-can significantly alter cardiac structure and function through hormonal excess,metabolic remodeling,and neurohumoral activation.Hyperthyroidism may lead to high-output heart failure(HF)and atrial fibrillation,while hypothyroidism is associated with diastolic dysfunction,pericardial effusion,and accelerated atherosclerosis.Acromegaly promotes biventricular hypertrophy and myocardial fibrosis via insulin-like growth factor 1 overproduction.Pheochromocytoma triggers catecholamine-induced cardiomyopathy,resembling Takotsubo syndrome and carrying a high risk of mortality if left untreated.Diabetes induces a distinct phenotype of cardiomyopathy,affecting both systolic and diastolic function through microvascular injury and oxidative stress.Recognizing these endocrine etiologies is crucial,as targeted hormonal therapies-such as antithyroid agents,somatostatin analogs,or adrenalectomy-can reverse or significantly mitigate cardiac dysfunction.Comprehensive endocrine screening in patients with unexplained cardiomyopathy is therefore essential.This review synthesizes current knowledge on the pathophysiological mechanisms,clinical manifestations,and therapeutic strategies for endocrine cardiomyopathies and proposes a diagnostic algorithm for early recognition.Emerging biomarkers,such as galectin-3 in diabetic heart disease,may further enhance diagnostic accuracy and risk stratification.The interplay between endocrine and cardiovascular systems offers a unique opportunity for early intervention,potentially preventing progression to irreversible HF. 展开更多
关键词 Endocrine cardiomyopathy Heart failure Thyroid disease Hormonal screening Cardiac remodeling
暂未订购 下载PDF
已选0条
引用分析
参考文献
引证文献
 统计分析
检索结果
已选文献
上一页 1 下一页 到第 页
在线咨询 使用帮助 返回顶部 意见反馈